News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
253–288
Matches
2439
Sources here
18
Companies here
20
Search results Stored financial headlines

Active search

2439 matching headlines

Ticker or company: LABMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Stock

Representative Richard Dean Dr McCormick of Georgia recently sold Abbott Laboratories (NYSE: ABT) stock worth between $25,025 and $375,000, according to records from August 14, 2026, with the transaction occurring on July 30, 2026. Congressional transactions, while not the sole basis for investment decisions, …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

20/20 Biolabs Q2 Results: EPS misses, revenue up 36%

20/20 Biolabs (NASDAQ: AIDX) reported a significant miss on its Q2 earnings per share, with a loss of $(0.26) against an estimated $(0.06), marking a 333.33% miss. Despite this, the company saw a 36.54% year-over-year revenue increase to $730.571K, though this also fell short …

AIDX main company
Sharemaestro market context Stored weekly price path 26 weeks -96.3% · Next-week setup negative 21.1% AIDX stored weekly price path from 20 Feb 2026 to 14 Aug 2026

Astera Labs (NASDAQ:ALAB) Growth Story Gets More Interesting

Astera Labs is gaining market attention due to its strengthened position in AI infrastructure, driven by increasing data-center connectivity demand and strong quarterly performance. The company specializes in high-speed connectivity solutions crucial for advanced AI systems, where efficient data movement and reliable communication are …

ALAB main company
Sharemaestro market context Trend signal active 52 weeks +79.6% · Next-week setup positive 59.8% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Astera Labs Inc Stock (ALAB) Opened Up by 7.14% on Aug 17: Key Drivers Unveiled

Astera Labs Inc (ALAB) stock rose 7.14% on August 17, driven by an upgrade from Northland Securities to "Outperform" with a higher price target, citing strong AI infrastructure investment and market share gains. The company reported record quarterly revenue, doubling year-over-year, and issued optimistic …

ALAB main company
Sharemaestro market context Trend signal active 52 weeks +79.6% · Next-week setup positive 59.8% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Top-Ranked ALAB & ANET Set to Thrive on AI-Cloud Networking Growth

The rapid expansion of AI infrastructure has created a strong opportunity for companies that supply computing and networking systems required to develop AI models. Moreover, AI infrastructure is moving toward faster links, larger accelerator clusters and more complex rack-scale topologies, significantly expanding connectivity content …

ALAB main company ALAB main company
Sharemaestro market context Trend signal active 52 weeks +56.7% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viasat Selects Rocket Lab to Build GEO Satellite for U.S. Space Force’s Protected Tactical SATCOM-Global Program

Rocket Lab Corporation Viasat and Rocket Lab will partner on delivery of maneuverable, anti-jam satellite for national security missions Rocket Lab Lightning PlatformViasat Selects Rocket Lab to Build GEO Satellite for U.S. Space Force's Protected Tactical SATCOM-Global Program CARLSBAD, Calif. and LONG BEACH, Calif., …

RKLB main company
Sharemaestro market context Price below Trend Line 52 weeks +80.8% · Next-week setup positive 55.7% RKLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Labcorp to host Investor Day Sept. 10 outlining strategy, capital priorities and outlook

Labcorp (LH) will host an Investor Day on September 10, 2026, to detail its strategy, capital allocation priorities, and long-term financial outlook. CEO Adam Schechter and CFO Julia Wang will present, followed by a Q&A session. A webcast replay and supporting materials will be …

LH main company
Sharemaestro market context Trend signal active 52 weeks +15.6% LH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Weekly Recap: AI diagnostics expansion and Barclays trims target to $710

IDEXX Laboratories (IDXX) is expanding its diagnostics, AI software, and product offerings, reporting strong recurring revenue growth and projecting high operating margins. Despite this positive outlook, Barclays has maintained its "Overweight" rating but adjusted its 12-month price target from $800 to $710.

IDXX main company
Sharemaestro market context Price below Trend Line 52 weeks -14.7% IDXX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Northland upgrades Astera Labs stock rating on AI spending outlook

Northland upgraded Astera Labs (NASDAQ:ALAB) to Outperform from Market Perform, setting a price target of $350 due to an anticipated extended AI infrastructure spending cycle and positive earnings revisions. The firm highlighted Astera Labs' strong position in AI infrastructure signal conditioning and its significant …

ALAB main company
Sharemaestro market context Trend signal active 52 weeks +79.6% · Next-week setup positive 59.8% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FDA closes Dr. Reddy’s (NYSE: RDY) UK plant inspection

Dr. Reddy's Laboratories Limited announced that the United States Food & Drug Administration (USFDA) has concluded and officially closed its inspection of the company's API manufacturing facility in Mirfield, West Yorkshire, United Kingdom. The inspection outcome was classified as "Voluntary Action Indicated (VAI)," meaning …

RDY main company
Sharemaestro market context Price below Trend Line 52 weeks -15.4% RDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Challenges with a 9.67% Potential Upside

Dr. Reddy’s Laboratories Ltd (RDY) is a significant player in the pharmaceutical sector with a $10.22 billion market capitalization and a potential upside of 9.67%. Despite a 5.60% revenue decline and negative free cash flow, the company offers a 0.68% dividend yield and operates …

RDY main company
Sharemaestro market context Price below Trend Line 52 weeks -15.4% RDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What's Going On With Rocket Lab Stock Monday?

Rocket Lab Corporation(NASDAQ:RKLB) stock traded nearly 1% higher during Monday's premarket session as technology stocks gained. Nasdaq futures rose 0.42%, while S&P 500 futures added 0.13%. The stock has posted a strong run over the past year. Investors are now watching whether it can …

RKLB main company
Sharemaestro market context Price below Trend Line 52 weeks +80.8% · Next-week setup positive 55.7% RKLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rocket Lab (RKLB) Deployed Eight Satellites In Its First Globalstar Constellation Mission

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Rocket Lab (NasdaqGS:RKLB) successfully launched and deployed eight satellites for MDA Space to support Globalstar's direct to device constellation. The mission marks the first …

RKLB main company
Sharemaestro market context Price below Trend Line 52 weeks +80.8% · Next-week setup positive 55.7% RKLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diamond Hill Capital Management LLC Investment Advisor Makes New Investment in Labcorp Holdings Inc. $LH

Diamond Hill Capital Management LLC Investment Advisor has acquired a new stake in Labcorp Holdings Inc. (NYSE:LH), purchasing 600,792 shares valued at approximately $168.22 million, making it their 26th largest holding. Other institutional investors have also significantly increased their positions in Labcorp, while company …

LH main company
Sharemaestro market context Trend signal active 52 weeks +15.6% LH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level

20/20 BioLabs (AIDX) reported strong Q2 2026 financial results, with total revenue up 36.5% to $0.7 million, largely driven by a 47.1% increase in OneTest™ cancer and longevity test revenue. The company also improved its gross profit significantly and strengthened its cash position by …

AIDX main company
Sharemaestro market context Stored weekly price path 26 weeks -96.3% · Next-week setup negative 21.1% AIDX stored weekly price path from 20 Feb 2026 to 14 Aug 2026

Cidel Asset Management Inc. Sells 184,792 Shares of Abbott Laboratories $ABT

Cidel Asset Management Inc. reduced its stake in Abbott Laboratories (NYSE:ABT) by 44.8% during the second quarter, selling 184,792 shares and holding 227,603 shares valued at $20.65 million. Other institutional investors also adjusted their positions. The article details Abbott Laboratories' financial performance, dividend announcement, …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fairvoy Private Wealth LLC Has $361,000 Stock Position in Abbott Laboratories $ABT

Fairvoy Private Wealth LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 86.2% in the second quarter, bringing its total holdings to $361,000. Despite this, several other institutional investors, including Vanguard Group Inc. and State Street Corp, increased their positions in ABT. Analyst …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Asio Capital LLC Buys Shares of 37,689 Abbott Laboratories $ABT

Asio Capital LLC recently acquired 37,689 shares of Abbott Laboratories (NYSE:ABT) valued at approximately $3.42 million. This comes as other institutional investors, including Vanguard Group Inc., State Street Corp, and Capital International Investors, also adjusted their significant holdings in the company. Abbott Laboratories has …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context